🇺🇸 AGI-1067 in United States

1 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 1

Most-reported reactions

1. Hepatitis — 1 report (100%)

Source database →

Frequently asked questions

Is AGI-1067 approved in United States?

AGI-1067 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for AGI-1067 in United States?

AtheroGenics is the originator. The local marketing authorisation holder may differ — check the official source linked above.